Department of Cell Physiology and Metabolism, Centre Medical Universitaire (CMU), Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Diabetes Centre, Faculty of Medicine, University of Geneva, 1211, Geneva, Switzerland.
Nat Commun. 2021 Dec 2;12(1):7031. doi: 10.1038/s41467-021-27133-7.
Intestinal surface changes in size and function, but what propels these alterations and what are their metabolic consequences is unknown. Here we report that the food amount is a positive determinant of the gut surface area contributing to an increased absorptive function, reversible by reducing daily food. While several upregulated intestinal energetic pathways are dispensable, the intestinal PPARα is instead necessary for the genetic and environment overeating-induced increase of the gut absorptive capacity. In presence of dietary lipids, intestinal PPARα knock-out or its pharmacological antagonism suppress intestinal crypt expansion and shorten villi in mice and in human intestinal biopsies, diminishing the postprandial triglyceride transport and nutrient uptake. Intestinal PPARα ablation limits systemic lipid absorption and restricts lipid droplet expansion and PLIN2 levels, critical for droplet formation. This improves the lipid metabolism, and reduces body adiposity and liver steatosis, suggesting an alternative target for treating obesity.
肠道表面的大小和功能发生变化,但推动这些变化的因素以及它们的代谢后果尚不清楚。在这里,我们报告食物量是肠道表面积的一个积极决定因素,有助于增加吸收功能,通过减少每日食物量可以逆转。虽然几个上调的肠道能量途径是可有可无的,但肠道 PPARα 对于基因和环境过量饮食引起的肠道吸收能力增加是必要的。在存在膳食脂质的情况下,肠道 PPARα 敲除或其药理学拮抗剂抑制小鼠和人类肠道活检中的肠隐窝扩张和绒毛缩短,减少餐后甘油三酯转运和营养吸收。肠道 PPARα 缺失限制了全身脂质吸收,并限制了脂质滴的扩张和 PLIN2 水平,这对形成脂质滴至关重要。这改善了脂质代谢,减少了体脂肪和肝脂肪变性,提示了治疗肥胖的另一个靶点。